CEO of Aerie Pharmaceuticals provides a brief company overview at OIS meeting
Vince Anido, Chairman & Chief Executive Officer of Aerie Pharmaceuticals, Inc., provides an update on the company's glaucoma drugs at the Ophthalmology Innovation Summit (OIS) meeting during the annual American Society of Retina Specialists (ASRS) conference in Vancouver, British Columbia, on July 20th, 2018.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Recent Videos
Related Content
